CellSource News and Activities
Presence
CellSource provides regenerative medicine support services, cell processing, and storage products for medical institutions. Its main customers are clinics and hospitals that offer orthopedic, cosmetic, and other cell-based treatments.
CellSource products and services overview:
- Cell processing
- Cell storage
- Regenerative medicine support
- PRP preparation
- Stem cell services
- Medical materials
Revenue: ~$60 million
Employees: 220
Headquarters: Tokyo, Japan
CellSource is one of the...
CellSource is a company listed under the stock ticker 4880 (JP).
Executives
View the org chart displaying its 13 main executives
Most searched biographies at CellSource
- Takashi Sawada, President, Chief Executive Officer and Representat...
- Takeshi Amemiya, Director
- Tsuneyasu Ozaki, Independent Director
Create your alert
to follow the executive moves at CellSource.
Pharmaceuticals
CellSource has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by CellSource
Social media about CellSource
- CellSource on Wikipedia, Google News & Yahoo Finance
- CellSource on LinkedIn, X (Twitter) & YouTube
